Skip to main content
CROX
NASDAQ Manufacturing

Crocs Seeks Shareholder Approval for New Equity Plan with 10.6% Potential Dilution Amidst HEYDUDE Impairment

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$104.22
Mkt Cap
$5.235B
52W Low
$73.205
52W High
$122.84
Market data snapshot near publication time

Summary

Crocs proposes a new equity incentive plan that could lead to 10.6% potential dilution, following a year with a net loss driven by a large HEYDUDE brand impairment.


Key Events

  • New Equity Incentive Plan Proposed

    Shareholders will vote on the 2026 Equity Incentive Plan, authorizing 2.2 million new shares for future equity awards to directors, executives, and other employees.

  • Significant Potential Dilution

    If approved and fully utilized, the new plan, combined with existing equity plans, could result in a potential future dilution of approximately 10.6% of outstanding common stock.

  • Challenging 2025 Financials

    The proposal follows a year where Crocs reported a net loss of $81.2 million, primarily due to a $738.1 million impairment charge on its HEYDUDE brand, and a 1.5% decrease in overall revenues.

  • Executive Compensation Details

    The filing details executive compensation for 2025, noting mixed performance-based payouts, including no payout for the 2023-2025 cumulative revenue PSU, and a CEO to median employee pay ratio of 290:1.


Analysis

The company is seeking shareholder approval for its 2026 Equity Incentive Plan, which would authorize 2.2 million new shares. Combined with existing equity plans, this represents a potential future dilution of approximately 10.6% of current outstanding common stock. This substantial potential dilution comes after a challenging 2025, marked by a significant net loss of $81.2 million due to a $738.1 million impairment charge on the HEYDUDE brand and a 13.3% decline in HEYDUDE revenues. While the plan includes sound governance features and is intended for talent attraction and retention, the magnitude of potential dilution in the context of recent financial underperformance is a key consideration for investors.

At the time of this filing, CROX was trading at $104.22 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $73.21 to $122.84. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CROX - Latest Insights

CROX
Jun 10, 2026, 12:51 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $123.23
Real-time Price: $124.60 info
Change: +$1.37 (+1%) info
Market Cap: $6.197B info
CROX
Jun 05, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $116.97
Real-time Price: $124.60 info
Change: +$7.63 (+7%) info
Market Cap: $6.197B info
CROX
Apr 30, 2026, 2:32 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $102.00
Real-time Price: $124.60 info
Change: +$22.60 (+22%) info
Market Cap: $6.197B info
CROX
Apr 30, 2026, 7:11 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $93.45
Real-time Price: $124.60 info
Change: +$31.15 (+33%) info
Market Cap: $6.197B info
CROX
Apr 30, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $97.14
Real-time Price: $124.60 info
Change: +$27.46 (+28%) info
Market Cap: $6.197B info
CROX
Apr 23, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $104.22
Real-time Price: $124.60 info
Change: +$20.38 (+20%) info
Market Cap: $6.197B info
CROX
Feb 12, 2026, 3:03 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $98.72
Real-time Price: $124.60 info
Change: +$25.88 (+26%) info
Market Cap: $6.197B info
CROX
Feb 12, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $93.69
Real-time Price: $124.60 info
Change: +$30.91 (+33%) info
Market Cap: $6.197B info